HHS-OIG

Infusion Association Asks For Kickback Safe Harbor For Expensive Biologics Drug manufacturers routinely offer…

On April 20, the U.S. Department of Health and Human Services Office of Inspector General (OIG) announced the release of a new a…

 The House Ways and Means Subcommittee on Oversight recently held a hearing on the federal government’s use of data analysis to…

Last week we posted a comprehensive look at the increased scrutiny into laboratories that engage in referrals with…

Referral arrangements between laboratories and physicians have received a lot of scrutiny lately. Last week, it was…

The HHS Office of Inspector General (OIG) yesterday announced that Sandoz Inc. will pay $12.64 million to settle allegations it…

HHS-OIG recently released their 2015 Health Reform Oversight Plan. The agency plans to hone in on the Affordable Care Act during…

Last week’s CBI Medical Device and Diagnostic Compliance Congress featured an “enforcement panel” that discussed recent trends in…

Each year the HHS Office of Inspector General (OIG) solicits recommendations for new or modified safe harbor provisions…

2014 has been a big year for healthcare and continuing medical education (CME). Here are ten topics worth going back to that…